ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.25
-0.40 (-7.08%)
May 19, 2026, 4:00 PM EDT - Market closed
ImageneBio Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, ImageneBio stock has a consensus rating of "Buy" and an average price target of $13. The average 1-year stock price forecast is 147.62% higher than the current stock price, while the lowest is $2.00 (-61.90%) and the highest is $24 (+357.14%).
Price Target: $13 (+147.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ImageneBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Reiterates $2 | Sell | Reiterates | $2 | -61.90% | May 11, 2026 |
| Wedbush | Wedbush | Sell Initiates $2 | Sell | Initiates | $2 | -61.90% | Nov 25, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $30 | Buy | Initiates | $30 | +471.43% | Oct 24, 2025 |
Financial Forecast
Revenue This Year
n/a
from 800.00K
Revenue Next Year
n/a
EPS This Year
-3.18
from -9.64
EPS Next Year
-2.69
from -3.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.67 | -1.47 | ||||||
| Avg | -3.18 | -2.69 | ||||||
| Low | -3.68 | -3.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.